Caveolin-1 and accelerated host aging in the breast tumor microenvironment: chemoprevention with rapamycin, an mTOR inhibitor and anti-aging drug.

MLA

Mercier, Isabelle, et al. “Caveolin-1 and Accelerated Host Aging in the Breast Tumor Microenvironment: Chemoprevention with Rapamycin, an MTOR Inhibitor and Anti-Aging Drug.” The American Journal of Pathology, vol. 181, no. 1, July 2012, pp. 278–93. EBSCOhost, https://doi.org/10.1016/j.ajpath.2012.03.017.

APA

Mercier, I., Camacho, J., Titchen, K., Gonzales, D. M., Quann, K., Bryant, K. G., Molchansky, A., Milliman, J. N., Whitaker-Menezes, D., Sotgia, F., Jasmin, J.-F., Schwarting, R., Pestell, R. G., Blagosklonny, M. V., & Lisanti, M. P. (2012). Caveolin-1 and accelerated host aging in the breast tumor microenvironment: chemoprevention with rapamycin, an mTOR inhibitor and anti-aging drug. The American Journal of Pathology, 181(1), 278–293. https://doi.org/10.1016/j.ajpath.2012.03.017

Chicago

Mercier, Isabelle, Jeanette Camacho, Kanani Titchen, Donna M Gonzales, Kevin Quann, Kelly G Bryant, Alexander Molchansky, et al. 2012. “Caveolin-1 and Accelerated Host Aging in the Breast Tumor Microenvironment: Chemoprevention with Rapamycin, an MTOR Inhibitor and Anti-Aging Drug.” The American Journal of Pathology 181 (1): 278–93. doi:10.1016/j.ajpath.2012.03.017.